VORAPAXAR (vor" a pax' ar) helps to prevent blood clots. It is used in patients with a previous heart attack or blockages in the arteries of the legs to reduce the risk of heart attack, stroke, or the need for procedures to restore blood flow to the heart. Compare antiplatelet drugs.

Zontivity Latest News

Get the latest updates on this drug from the GoodRx medical team

New Anticoagulant Med Zontivity: Now FDA Approved!

The GoodRx Pharmacist - May 19, 2014

Zontivity (voraxapar) is a new type of anti-platelet medication for people who have had a heart attack, or who have reduced blood flow in their legs. It is used to reduce the risk of heart attack, stroke, cardiovascular death, and the need for procedures to restore blood flow to the heart. It was approved by the FDA in May 2014, and will be available from manufacturer Merck later this year.

When will Zontivity be available?

According to the manufacturer the anticipated availability date for this medication is the third quarter of 2014. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.